Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 04 symbols : NVSEF save search
Worldwide Gene Therapy Industry to 2027 - Players Include Amgen, Biogen and Novartis Among Others
Published: 2022-03-04 (Crawled : 21:00) - prnewswire.com
QURE | $4.83 3.43% 3.31% 380K
|
Health Technology
| Email alert
Add to watchlist
ABEO | News | $7.4 -2.25% -2.3% 480K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BIIB | $194.1 -0.14% -0.15% 1.1M
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.5 -1.11% 1M
|
Manufacturing
| Email alert
Add to watchlist
AMGN | News | $271.98 1.13% 1.12% 2.1M
|
Health Technology
| Email alert
Add to watchlist
ADAP | $1.03 5.46% 5.17% 690K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.75 43.47% 200
|
Health Technology
| Email alert
Add to watchlist
novartis gene therapy therapy
Global Dry Eye Syndrome Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-03-04 (Crawled : 20:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.59 2.11% -0.36% 3.8M
|
Health Technology
| Email alert
Add to watchlist
dry eye eye growth syndros
Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
Published: 2022-03-04 (Crawled : 14:30) - globenewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -3.34%
H: 0.0%
C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: -3.45%
H: 0.0%
C: 0.0%
novartis pos solutions
Worldwide Pain Management Drugs Industry to 2030 - Rise in Number of Cases of Chronic Disorders is Driving Growth
Published: 2022-03-04 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.37%
H: 0.0%
C: -3.7%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -3.34%
H: 0.0%
C: 0.0%
VTRS | News A | $11.235 -0.13% -0.13% 5.1M
|
Health Technology
|
| O: -3.54%
H: 0.0%
C: 0.0%
PFE | News A | $26.26 1.0% -0.08% 36M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: -3.45%
H: 0.0%
C: 0.0%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
GSK | News | $40.59 2.11% -0.36% 3.8M
|
Health Technology
|
| O: -4.03%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
order drug growth
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.